PCAT19 and posterior cortical atrophy: Although PCAT19 does not predict biochemical recurrence-free survival in general, PCa patients with the rs11672691 GG genotype and higher PCAT19 expression are at increased risk of biochemical relapse (Gao et al., 2018).